We are developing a novel strategy to combat challenging respiratory diseases and inflammation fueled by biofilms. Learn more about our important work to address the burden of biofilm-mediated infections and the resulting inflammation and bronchiectasis.

An innovative, strategically focused management team with deep therapeutic and vaccine development expertise.

In the News